Mechanism underlying the transient increase of serum iron during FOLFOX/FOLFIRI therapy

Author：

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.6, 2014-01, pp. : 968-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W. Ermers M.J.J. Pootrakul P. Abramov A. Hershko C. Ioav Cabantchik Z.

Transfusion and Apheresis Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite

Desferrioxamine-chelatable iron (DCI), a component of serum non-transferrin-bound iron (NTBI) used for assessing iron chelation therapy

By Breuer W. Ermers M.J.J. Pootrakul P. Abramov A. Hershko C. Ioav Cabantchik Z.

Transfusion Science, Vol. 23, Iss. 3, 2000-12 ,pp. : 241-242

Elsevier

Access to resources Recommend Favorite

Vitamin B12 and folate levels increase during treatment of iron deficiency anaemia in young adult woman

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 641-648

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Th1 and Th2 cytokines with transient inflammatory reaction during lenalidomide plus dexamethasone therapy in multiple myeloma

By Harada Takeshi

International Journal of Hematology, Vol. 97, Iss. 6, 2013-06 ,pp. : 743-748

Springer Publishing Company

Access to resources Recommend Favorite

Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis

By Naclerio Robert M. Pinto Jayant deTineo Marcy Baroody Fuad M.

Allergy and Asthma Proceedings, Vol. 29, Iss. 1, 2008-01 ,pp. : 24-28

OceanSide Publications, Inc

Access to resources Recommend Favorite